Buradasınız

Anasayfa » Content

Böbrek Naklinin Geç Dönemde Kalp İşlevleri ve Yapısına Etkisi

Effects of Renal Transplantation on Cardiac Function and Morphology in the Late Posttransplant Period

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2012
DOI: 
DOI 10.5262/tndt.2012.1001.05

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
OBJECTIVE: To investigate the effects of renal transplantation on left ventricular (LV) function and morphology in patients with end-stage renal disease (ESRD) in the late posttransplant period. MATE RIAL and Methods: The prospective study included 40 patients (mean age 33.2 ± 7.7 years;25 female /15 male) with ESRD. In all of these patients, renal transplantation was performed successfully; and the serum creatinine levels were less than 2 mg/dL. The echocardiographic evaluations were performed before renal transplantation and 12. month after renal transplantation. Left ventricular diastolic diameter (LVDD), left ventricular systolic diameter (LVESD), left ventricular mass (LV Mass), left ventricular mass index (LVMI), LV ejection fraction (LVEF), Doppler and tissue Doppler parameters were obtained in all patients. Res ults: At the twelfth month, LVDD (48 ± 5 vs 45 ± 6, p: 0.01), LVSD (33 ± 4 vs 29 ± 4, p< 0.001) LVMI (114 ± 31 vs 98 ± 13, p: 0.007) decreased significantly compared to the pretransplant period. There was a significant increase in the LVEF in at the twelfth month (59 ± 5 vs 67 ± 6, p< 0.001). There was a significant improvement between pretransplant period and late posttransplant period with regard to diastolic cardiac function. ConclusI on: Renal transplantation had beneficial effects on diastolic and systolic functions and cardiac morphology in the late posttransplant period.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç : Son dönem böbrek yetmezliği ile izlenen hastalarda nakil sonrası geç dönemde naklin sol ventrikül işlev ve yapısı üzerine etkisini araştırmayı planladık. GEREÇ ve YÖNTEMLER: 25 kadın /15 erkek olmak üzere 40 son dönem böbrek yetmezliği hastası ile yapılan bu ileri dönük çalışmada tüm hastalara başarılı bir şekilde böbrek nakli yapılmıştır (Tüm hastaların kreatin değerleri (<2mg/dl). Tüm hastalara nakil öncesi ve sonrası 12.ayda ekokardiyografik değerlendirme yapıldı. Bu ekokardiyografik incelemelerde tüm hastalarda sol ventriküler diastolik çap, sol ventriküler sistolik çap, sol ventrikül kitlesi, sol ventrikül kitle indeksi, sol ventriküler ejeksiyon fraksiyonu ayrıca doppler inceleme ve doku dopleri yapıldı. BUL GUL AR: On ikinci ayda, sol ventriküler diastolik çap (48 ± 5 vs 45 ± 6, p: 0.01), sol ventriküler sistolik çap (33 ± 4 vs 29 ± 4, p< 0.001) sol ventriküler kitle indeksi (114 ± 31 vs 98 ± 13, p: 0.007) nakil öncesi döneme göre anlamlı şekilde azalmıştır. Sol ventrikül ejeksiyon fraksiyonu on ikinci ayda anlamlı olarak artmıştır (59 ± 5 vs 67 ± 6, p< 0.001). Nakil öncesi döneme göre geç nakil sonrası dönemde diyastolik kardiyak işlevlerde anlamlı bir düzelme görülmektedir. Sonuç: Böbrek naklinin geç dönemde kardiyak yapı ve kalbin sistolik ve diyastolik işlevleri üzerine yararlı etkilerinin olduğu gösterilmiştir.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_21_pp_28-33.pdf
  • 1
28-33
  • Turkish

REFERENCES

References: 

Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P:
Electrocardiographic left ventricular hypertrophy in renal transplant
recipients: Prognostic value and impact of blood pressure and
anemia. J Am Soc Nephrol 2003; 14: 462-468
2. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE:
Long-term evolution of cardiomyopathy in dialysis patients. Kidney
Int 1998; 54: 1720-1725
3. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre
PE, Guttmann RD: Impact of renal transplantation on uremic
cardiomyopathy. Transplantation 1995; 60: 908-914
4. McMahon LP, Roger SD, Levin A: Slimheart Investigators Group.
Development, prevention, and potential reversal of left ventricular
hypertrophy in chronic kidney disease. J Am Soc Nephrol 2004; 15:
1640-1647
5. Unger P, Velez-Roa S, Wissing KM: Regression of left ventricular
hypertrophy after arteriovenous fistula closure in renal transplant
recipients: A long-term follow-up. Am J Transplant 2004; 4:
2038-2044
6. Hernández D, González A, Rufino M, Laynez I, de la Rosa A, Porrini
E, Lacalzada J, Barragán A, Lorenzo V, Torres A: Time-dependent
changes in cardiac growth after kidney transplantation: The impact
of pre-dialysis ventricular mass. Nephrol Dial Transplant 2007; 22:
2678-2685
7. Rigatto C, Foley RN, Kent GM: Longterm changes in left ventricular
hypertrophy after renal transplantation. Transplantation 2000; 70:
570-575
8. Ferreira SR, Moises VA, Tavares A, Pacheco-Silva A: Cardiovascular
effects of successful renal transplantation: A 1-year sequential study
of left ventricular morphology and function, and 24-hour blood
pressure profile. Transplantation 2002; 74: 1580-1587
9. Patel RK, Mark PB, Johnston N: Renal transplantation is not
associated with regression of left ventricular hypertrophy: A
magnetic resonance study. Clin J Am Soc Nephrol 2008; 3:
1807-1811
10. Hernandez D, Lacalzada J, Rufino M, Torres A, Martín N, Barragán
A, Barrios Y, Macía M, de Bonis E, Lorenzo V, Rodríguez A,
González-Posada JM, Salido E: Prediction of left ventricular
mass changes after renal transplantation by polymorphism of
the angiotensin-converting-enzyme gene. Kidney Int 1997 ; 51:
1205-1211
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster
E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise
JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ;
Chamber Quantification Writing Group; American Society of
Echocardiography’s Guidelines and Standards Committee;
European Association of Echocardiography: Recommendations
for chamber quantification: a report from the American Society of
Echocardiography’s Guidelines and Standards Committee and the
Chamber Quantification Writing Group, developed in conjunction
with the European Association of Echocardiography, a branch of the
Europea Society of Cardiology. J Am Soc Echocardiography 2005;
18: 1440-1463
12. Devereux RB, Reichek N: Echocardiographic determination of left
ventricular mass in man. Anatomic validation of the method. 1977;
55: 613-618
13. Nishimura RA, Tajik AJ: Evaluation of diastolic filling of left
ventricle in health and disease: Doppler echocardiography is the
clinician’s Rosetta Stone. J Am Coll Cardiol 1997; 30: 8-18
14. Chen L, Benjamin EJ, Larson MG, Evans JC, Levy D: Doppler
diastolic filling indexes in relation to disease states. Am Heart J
1996; 131: 519-524
15. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS,
Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B:
Prognostic significance of left ventricular mass change during
treatment of hypertension. JAMA 2004; 292: 2350-2356
16. Mosteller RD: Simplified calculation of body surface area. N Engl J
Med 1987; 317: 1098
17. Kessler M, Zannad F, Lehert P, Grünfeld JP, Thuilliez C, Leizorovicz
A, Lechat P; FOSIDIAL Investigators: Predictors of cardiovascular
events in patients with end-stage renal disease: An analysis from
the Fosinopril in Dialysis study. Nephrol Dial Transplant 2007; 22:
3573-3579
18. Dudziak M, Debska-Slizień A, Rutkowski B: Cardiovascular
effects of successful renal transplantation: A 30-month study on left
ventricular morphology, systolic and diastolic functions. Transplant
Proc 2005; 37: 1039-1043
19. Iqbal MM, Banerjee SK, Rahman MH, Rashid HU: Cardiac
functional and morphologic changes of renal allograft recipients
in the early posttransplant period. Transplant Proc 2006; 38:
3527-3529
20. Hernández D: Left ventricular hypertrophy after renal
transplantation: New approach to a deadly disorder. Nephrol Dial
Transplant 2004; 19: 1682-1686
21. Arce Salinas CA, Bolaños Ulloa F, Delgado Toledano MA,
Caballero Hermosillo JA, Alvarez Amador L, Martínez-Reding JO:
Changes in the mass and function of the left ventricle after renal
Transplantation. Arch Inst Cardiol Mex 1991; 61: 527- 532
22. Espino G, Denney J, Furlong T, Fitzsimmons W, Nash RA:
Assessment of myocardial hypertrophy by echocardiography in
adult patients receiving tacrolimus or cyclosporine therapy for
prevention of acute GVHD. Bone Marrow Transplant 2001; 28:
1097-1103
23. Ji SM, Li LS, Sha GZ, Chen JS, Liu ZH: Conversion from
cyclosporine to tacrolimus for chronic allograft nephropathy.
Transplant Proc 2007; 39: 1402-1405
24. Bialostozky D, Leyva M, Villarreal T, Casanova JM, Pérez-Grovas
H, Lemus P, Jiménez G, Vallejo E, Jiménez-Angeles L, Herrera
J, Altamirano J: Myocardial perfusion and ventricular function
assessed by SPECT and Gated-SPECT in end-stage renal disease
patients before and after renal transplant. Arch Med Res 2007; 38:
227-233
25. Sahagún-Sánchez G, Espinola-Zavaleta N, Lafragua-Contreras
M, Chávez PY, Gómez-Núñez N, Keirns C, Romero-Cardenas A,
Pérez-Grovas H, Acosta JH, Vargas-Barrón J: The effect of kidney
transplant on cardiac function: An echocardiographic perspective.
Echocardiography 2001; 18: 457-462

Thank you for copying data from http://www.arastirmax.com